Alligator Bioscience: Trading of Alligator Bioscience AB on Nasdaq Stockholm commences today

Press release, November 23, 2016

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY,
IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY
OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION
WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.

Alligator Bioscience AB ("Alligator" or the "Company"), a leading
biotech company developing innovative immune activating antibody
drugs for tumor-directed immunotherapy, hereby announces the outcome
relating to the offering to acquire shares in the Company (the
"Offering") and listing on Nasdaq Stockholm. The Offering attracted
strong interest among Swedish and international investors and the
Offering was oversubscribed several times.

For more information, see http://alligatorbioscience.se/en/news/

-----------------------------------------------------------
http://feed.ne.cision.com/client/waymaker1/WOLReleaseFile.aspx?id=378400...
http://mb.cision.com/Main/12681/2129059/594102.pdf